BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 14632808)

  • 1. A 6-month prospective survey of cutaneous drug reactions in a hospital setting.
    Fiszenson-Albala F; Auzerie V; Mahe E; Farinotti R; Durand-Stocco C; Crickx B; Descamps V
    Br J Dermatol; 2003 Nov; 149(5):1018-22. PubMed ID: 14632808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey.
    Hunziker T; Künzi UP; Braunschweig S; Zehnder D; Hoigné R
    Allergy; 1997 Apr; 52(4):388-93. PubMed ID: 9188919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cutaneous adverse drug reaction: prospective study of 118 cases].
    Chaabane H; Masmoudi A; Amouri M; Ghorbel S; Boudaya S; Hammami S; Zghal K; Turki H
    Tunis Med; 2013; 91(8-9):514-20. PubMed ID: 24227509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cross-sectional study of cutaneous drug reactions in a private dental college and government medical college in eastern India.
    Chattopadhyay C; Chakrabarti N
    Niger J Clin Pract; 2012; 15(2):194-8. PubMed ID: 22718172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous adverse drug reactions in a hospital setting.
    Rademaker M; Oakley A; Duffill MB
    N Z Med J; 1995 May; 108(999):165-6. PubMed ID: 7753511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of adverse cutaneous drug reactions in 22,866 Chinese inpatients: a prospective study.
    Tian XY; Liu B; Shi H; Zhao ZR; Zhou XP; Zhang T; Sun QN; Zuo YG
    Arch Dermatol Res; 2015 Nov; 307(9):829-34. PubMed ID: 26246330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of cutaneous adverse drug reactions among medical inpatients of Sultanah Aminah Hospital Johor Bahru.
    Latha S; Choon SE
    Med J Malaysia; 2017 Jun; 72(3):151-156. PubMed ID: 28733562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of adverse cutaneous drug reactions. A prospective study in hospitalized patients.
    Hernández-Salazar A; Rosales SP; Rangel-Frausto S; Criollo E; Archer-Dubon C; Orozco-Topete R
    Arch Med Res; 2006 Oct; 37(7):899-902. PubMed ID: 16971233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe cutaneous reactions to drugs in the setting of a general hospital.
    Grando LR; Schmitt TA; Bakos RM
    An Bras Dermatol; 2014; 89(5):758-62. PubMed ID: 25184915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous drug reactions in patients admitted to the dermatology unit at the University Hospital of the West Indies, Kingston, Jamaica.
    East-Innis AD; Thompson DS
    West Indian Med J; 2009 Jun; 58(3):227-30. PubMed ID: 20043529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adverse cutaneous reactions to drugs among hospitalized patients: a one year surveillance].
    Danza A; López M; Vola M; Alvarez-Rocha A
    Rev Med Chil; 2010 Nov; 138(11):1403-9. PubMed ID: 21279253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous adverse drug reactions seen at a university hospital department of dermatology.
    Borch JE; Andersen KE; Bindslev-Jensen C
    Acta Derm Venereol; 2006; 86(6):523-7. PubMed ID: 17106600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse cutaneous drug reactions in a single quaternary referral hospital.
    Botelho LF; Porro AM; Enokihara MM; Tomimori J
    Int J Dermatol; 2016 Apr; 55(4):e198-203. PubMed ID: 26710962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Retrospective analysis of adverse cutaneous drug reactions in patients hospitalized in Department of Dermatology and Venereology of Pomeranian Medical University in 1996-2006].
    Kacalak-Rzepka A; Klimowicz A; Bielecka-Grzela S; Załuga E; Maleszka R; Fabiańczyk H
    Ann Acad Med Stetin; 2008; 54(2):52-8. PubMed ID: 19374232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of acute generalized exanthematous pustulosis in Israel during 2002-2005: results of the RegiSCAR Study.
    Davidovici B; Dodiuk-Gad R; Rozenman D; Halevy S;
    Isr Med Assoc J; 2008 Jun; 10(6):410-2. PubMed ID: 18669133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of cutaneous drug-induced reactions.
    Naldi L; Crotti S
    G Ital Dermatol Venereol; 2014 Apr; 149(2):207-18. PubMed ID: 24819642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An observational study of cutaneous adverse drug reactions in a teaching hospital.
    Chopra D; Sharma V; Kapoor R; Dwivedi S
    Int J Clin Pharm; 2015 Dec; 37(6):996-9. PubMed ID: 26238222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cutaneous adverse drug reactions: clinical aspects and identification].
    Kardaun SH
    Ned Tijdschr Geneeskd; 2013; 157(11):A5823. PubMed ID: 23484517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causative drugs for drug-induced cutaneous reactions in central China: a 608-case analysis.
    Zhao J; Hu L; Zhang L; Zhou M; Gao L; Cheng L
    An Bras Dermatol; 2019; 94(6):664-670. PubMed ID: 31789251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe cutaneous hypersensitivity reactions during treatment of tuberculosis in patients with HIV infection in Tanzania.
    Dukes CS; Sugarman J; Cegielski JP; Lallinger GJ; Mwakyusa DH
    Trop Geogr Med; 1992 Oct; 44(4):308-11. PubMed ID: 1284179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.